Skip to main content
Clinical Trials/ISRCTN44617730
ISRCTN44617730
Active, not recruiting
未知

A registry of clinical and MRI outcomes following early versus late initiation of anticoagulation after ischaemic stroke or transient ischaemic attack in patients with atrial fibrillation

Australasian Stroke Academy0 sites280 target enrollmentMay 15, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Australasian Stroke Academy
Enrollment
280
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2018
End Date
April 1, 2022
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Australasian Stroke Academy

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who present with an acute ischaemic stroke or TIA of cardioembolic (atrial fibrillation \[AF]\-related) origin and who have an MRI following their primary ischaemic event, and are deemed suitable for initiation of NOAC or VKA therapy
  • 2\. Subjects must be enrolled within 30 days of symptom onset

Exclusion Criteria

  • 1\. Evidence of primary intracranial haemorrhage
  • 2\. Inability to have baseline and follow\-up MRI

Outcomes

Primary Outcomes

Not specified

Similar Trials